When was Tasmar approved by the FDA?

Written by Ana de Barros, PhD |

A

When was Tasmar approved by the FDA?

Category: Tasmar

The U.S. Food and Drug Administration approved Tasmar in January 1998 as an add-on treatment to ease symptoms in Parkinson’s patients receiving levodopa and carbidopa. However, due to an increased risk of liver failure, the therapy is only recommended for patients experiencing motor fluctuations and who failed to respond to or who are not candidates for other similar therapies.

Ana de Barros, PhD avatar

About the Author

Ana de Barros, PhD Ana holds a PhD in immunology from the University of Lisbon and worked as a postdoctoral researcher at Instituto de Medicina Molecular (iMM) in Lisbon, Portugal. Ana was awarded two FCT fellowships and has won the Portuguese Immunology Society Best Paper and Best Poster award in 2009 and 2010, as well as the CESPU International Research Award in 2010. After leaving the lab to pursue a career in science communication, she served as the director of science communication at iMM Lisbon.